Innovative Visualization and Quantification of Extracellular Vesicles Interaction with and Incorporation in Target Cells in 3D Microenvironments.
Cartilage, Articular
/ cytology
Cell Communication
Cells, Cultured
Cellular Microenvironment
Chondrocytes
/ cytology
Endocytosis
Extracellular Vesicles
/ metabolism
Female
Fibroblasts
/ cytology
Humans
Hyaluronic Acid
/ isolation & purification
Lab-On-A-Chip Devices
Mesenchymal Stem Cells
/ cytology
Middle Aged
Phenotype
Synoviocytes
/ cytology
confocal microscopy
extracellular matrix
extracellular vesicles
flow cytometry
mesenchymal stem cells
microfluidics
orthopedics
osteoarthritis
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
09 05 2020
09 05 2020
Historique:
received:
31
03
2020
revised:
30
04
2020
accepted:
06
05
2020
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
27
2
2021
Statut:
epublish
Résumé
Extracellular vesicles (EVs) showed therapeutic properties in several applications, many in regenerative medicine. A clear example is in the treatment of osteoarthritis (OA), where adipose-derived mesenchymal stem cells (ASCs)-EVs were able to promote regeneration and reduce inflammation in both synovia and cartilage. A still obscure issue is the effective ability of EVs to be internalized by target cells, rather than simply bound to the extracellular matrix (ECM) or plasma membrane, since the current detection or imaging technologies cannot fully decipher it due to technical limitations. In the present study, human articular chondrocytes (ACHs) and fibroblast-like synoviocytes (FLSs) isolated from the same OA patients were cocultured in 2D as well as in 3D conditions with fluorescently labeled ASC-EVs, and analyzed by flow cytometry or confocal microscopy, respectively. In contrast with conventional 2D, in 3D cultures, confocal microscopy allowed a clear detection of the tridimensional morphology of the cells and thus an accurate discrimination of EV interaction with the external and/or internal cell environment. In both 2D and 3D conditions, FLSs were more efficient in interacting with ASC-EVs and 3D imaging demonstrated a faster uptake process. The removal of the hyaluronic acid component from the ECM of both cell types reduced their interaction with ASC-EVs only in the 2D system, showing that 2D and 3D conditions can yield different outcomes when investigating events where ECM plays a key role. These results indicate that studying EVs binding and uptake both in 2D and 3D guarantees a more precise and complementary characterization of the molecular mechanisms involved in the process. The implementation of this strategy can become a valuable tool not only for basic research, but also for release assays and potency prediction for clinical EV batches.
Identifiants
pubmed: 32397409
pii: cells9051180
doi: 10.3390/cells9051180
pmc: PMC7291305
pii:
doi:
Substances chimiques
Hyaluronic Acid
9004-61-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Histochem Cytochem. 2008 Oct;56(10):901-10
pubmed: 18574248
Biomed Res Int. 2014;2014:619829
pubmed: 24575409
Curr Stem Cell Res Ther. 2019;14(6):482-494
pubmed: 30819086
Eur J Pharm Sci. 2017 Jan 1;96:316-322
pubmed: 27720897
Neoplasia. 2013 Aug;15(8):875-87
pubmed: 23908589
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Stem Cell Res Ther. 2019 Mar 29;10(1):109
pubmed: 30922413
J Extracell Vesicles. 2013 Jan 10;2:
pubmed: 24009896
Matrix Biol. 2019 Jan;75-76:201-219
pubmed: 29066152
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Biotechnol Bioeng. 2015 Jul;112(7):1457-71
pubmed: 25678107
Cytotechnology. 2015 Jan;67(1):19-26
pubmed: 24287612
Adv Exp Med Biol. 2018;1064:253-261
pubmed: 30471038
J Cell Biol. 2006 Jan 2;172(1):9-18
pubmed: 16390995
Stem Cells. 2014 Jun;32(6):1408-19
pubmed: 24578244
Mol Biol Cell. 2014 May;25(9):1511-22
pubmed: 24623723
Cell Commun Signal. 2016 Jan 12;14:2
pubmed: 26754424
Cancer Lett. 2015 Aug 1;364(1):59-69
pubmed: 25933830
Matrix Biol. 2017 Dec;64:54-68
pubmed: 28483644
J Extracell Vesicles. 2014 Aug 04;3:
pubmed: 25143819
Exp Mol Med. 2019 Mar 15;51(3):1-12
pubmed: 30872574
Arthritis Rheumatol. 2015 Jun;67(6):1503-13
pubmed: 25708025
J Extracell Vesicles. 2015 Apr 20;4:26316
pubmed: 25899407
Cells. 2019 Jul 15;8(7):
pubmed: 31311206
Lab Chip. 2018 Jan 16;18(2):249-270
pubmed: 29143053
Trends Cell Biol. 2015 Jun;25(6):364-72
pubmed: 25683921
Joints. 2019 Jul 25;6(4):215-219
pubmed: 31879717
Exp Cell Res. 1968 Jan;49(1):181-93
pubmed: 5640690
Acta Biomater. 2012 Nov;8(11):4031-42
pubmed: 22828381
Nat Rev Rheumatol. 2016 Apr;12(4):243-9
pubmed: 26729461
Front Mol Biosci. 2017 Nov 28;4:79
pubmed: 29234666
Osteoarthritis Cartilage. 2007 Sep;15(9):1034-41
pubmed: 17442595
Nat Commun. 2015 May 13;6:7164
pubmed: 25968605
Nature. 2014 Mar 13;507(7491):181-9
pubmed: 24622198
Stem Cell Rev Rep. 2019 Oct;15(5):743-754
pubmed: 31161551
Oncotarget. 2017 Nov 18;8(66):109894-109914
pubmed: 29299117
Biochim Biophys Acta Gen Subj. 2018 May;1862(5):1091-1100
pubmed: 29410228
Stem Cell Res Ther. 2019 Nov 21;10(1):340
pubmed: 31753036